Vevey / IRCC / Barcelona / Caen / Boston / Baltimore / Rotterdam / Paris / Lausanne / London / Lyon / Brussels / Grenoble / Marseille / Roche Glycart / /
Company
Auriga Partners / ERYTech Pharma / EORTC / /
Continent
Europe / /
Country
Switzerland / Netherlands / Italy / Belgique / Belgium / France / United States / United Kingdom / Spain / /
Currency
EUR / / /
Facility
Medicine University / Loire Cancer Institute / Erasmus Medical Center / Imperial College / Cancer Center / University of Lausanne Hospital Center / Lyon Research Center / National Institute / Centre Léon Bérard / National Cancer Institute / Lyon Civil Hospital / Hammersmith Hospital / University of Torino / Massachusetts Institute of Technology / Cancer Research Center / Infectiology Center / Albert Bonniot Institute / Pasteur Institute / South Lyon Hospital / /
IndustryTerm
non recours aux droits et services / Online registration / /
MedicalCondition
Progress Against Cancer / Hematological Malignancies / Childhood Leukaemia / Solid Tumors / Cancer Inégalités et Cancer Infections / breast cancer / patients atteints du cancer / Cancer / Tumor Microenvironment L. TAMAGNONE / HPV / et de non participation aux dépistages organisés du cancer / tumour / Nutrition et Cancer / recherches en épidémiologie du cancer / Inégalités socio-économiques et Cancer / maladies neuro-dégénératives au cancer / Exposition professionnelle au trichloréthylène et cancer / eicosanoïdes et risque de cancer S. BASU / Rare Tumors / /
Organization
Cancer Research Center of Lyon / National Cancer Institute / Erasmus Medical Center / Infectiology Center / National Institute for Medical Research / Centre de RMN / Albert Bonniot Institute / South Lyon Hospital / Center for the Study of Drug Development / Center for Clinical Investigations / Massachusetts Institute of Technology / Superior School of Biotechnology / Lyon Civil Hospital / Imperial College / Medicine University / équipe Institut de Recerca / Lyon Research Center of Lyon / Institut d’Études / RTH Laennec School of Medicine / Institute for Bioengineering / John HOPKINS School of Medicine / University of Torino / Pasteur Institute / Pierre Fabre Immunology Center / Lausanne Hospital Center / Lyon Léon Bérard Cancer Center / Loire Cancer Institute / Tufts University School of Medicine / Hammersmith Hospital / /
Person
Claude Bernard Lyon / Pierre Fabre / Léon Bérard / Carlos Accès / / /
Position
Chairperson / Model of the Sarcoma Group / /
ProvinceOrState
Massachusetts / /
Technology
alpha / Antibodies / Biotechnology / Drug Development / /